DOXA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.61 SEK | -1.88% |
|
-5.09% | -23.35% |
| Apr. 10 | Doxa AB announced that it has received SEK 200 million in funding | CI |
| Feb. 15 | Doxa AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Doxa AB is a Sweden-based company which develops products based on bio-active ceramics. The Company develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
Calendar
2024-05-14
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -23.35% | 139M | |
| +36.16% | 27.94B | |
| -13.74% | 26.97B | |
| +25.00% | 26.95B | |
| -0.71% | 25.32B | |
| +44.49% | 22.58B | |
| +2.78% | 19.59B | |
| +1.45% | 19.52B | |
| +28.54% | 16.23B | |
| -14.80% | 14.98B |
- Stock Market
- Equities
- DOXA Stock
- News Doxa AB
- Serneke Receives Public Takeover Offer From Doxa
